Bridgewater Bancshares reports Q2 earnings today with options traders positioned more defensively than at almost any point in the past year.
The options market is the clearest signal heading into the release. The put/call ratio has jumped to 12.1 — nearly three standard deviations above its 20-day average of 6.1, and close to its 52-week peak of 15.7. That kind of defensive skew is unusual even by BWB's own standards, where puts have historically dominated the options landscape. The move comes as the stock has gained 11% over the past month to close at $21.89, sitting just below the analyst consensus target of $22.75 — so options buyers appear to be hedging a run that may have already priced in the good news.
Short interest, by contrast, tells a low-pressure story. Shorts amount to just 1.4% of the free float — a level that carries little squeeze risk either way. Borrowing conditions remain relaxed: availability is effectively unlimited in this name, and while the cost to borrow has nearly doubled over the past month to 0.95%, it is still near rock-bottom in absolute terms. The ORTEX short score sits at 31.6, drifting modestly lower over the past two weeks — consistent with a market that is not meaningfully positioned for a down move.
The bull and bear debate centres on whether BWB's momentum is sustainable rather than whether the franchise is sound. Bulls point to raised full-year loan growth guidance — now targeting high single digits versus mid-to-high before — alongside resilient core deposit expansion and a track record of consistently beating estimates (EPS surprise ranks in the 95th percentile of the universe). DA Davidson holds a Buy and Piper Sandler carries an Overweight; both lifted targets after January's print. Bears flag elevated operating expenses, limited geographic diversification, and concentrated commercial real estate exposure as risks that could bite if the macro environment softens. The most recent analyst note — DA Davidson maintaining Buy at $22 after April's results — hasn't been updated since, and the stock has since traded above that target. One wrinkle on the ownership side: the founder and a cluster of other insiders were consistent net sellers through May and early June at prices in the $18–$19 range, netting roughly $1.2 million in combined proceeds. The stock has since rallied 15% above those sale prices, which frames insider activity as profit-taking rather than a confidence signal.
The print will test whether management can back the upgraded loan growth guidance with hard numbers on net interest margin trajectory — and whether credit quality in the commercial real estate book remains as clean as bulls have assumed.
See the live data behind this article on ORTEX.
Open BWB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
